COVID-19 Diagnostics: Introduction
COVID-19, first detected in China in late 2019 and has since been declared a pandemic, is posing both a serious threat to vulnerable populations and a challenge to the global economy. COVID-19 has the potential to take lives, overwhelm health systems, deplete the value of assets, and trigger lasting geopolitical change, as confirmed cases of COVID-19 increase and spread
Read Report Overview - https://www.transparencymarketresearch.com/covid19-diagnosticsmarket.html Key Drivers and Restraints of Global COVID-19 Diagnostics market
COVID-19, caused by a coronavirus, has been spreading rampantly across the globe. People infected with coronavirus experience symptoms of mild to moderate respiratory illnesses. The disease is known to spread through the respiratory droplets of an infected person. Use of face masks was advocated for infected persons to curb the spread of the disease. As of November, 2020, the disease has spread to over 218 countries, globally, infecting over 60 million people. Growing scare of infection among people and the asymptomatic spread of the disease have created a strong demand for COVID-19 diagnostics. Furthermore, ongoing efforts to flatten the curve of infection, globally, have prompted contact tracing and rapid diagnostic tests, which is likely to minimize the spread of the infection. Growing pandemic of COVID-19 and rising fear among people, along with healthcare care professionals advocating early diagnostics to reduce the risk of infection, fuel the COVID-19 diagnostics market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=80305 RT-PCR Test to Lead Global Market
The global COVID-19 diagnostics market can be segmented based on test type, end-user, and region In terms of test type, the global COVID-19 diagnostics market can be divided into polymerase chain reaction (PCR), POC test, and immunoassay test. PCR tests are utilized to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies. Currently, there are two types of diagnostic tests– molecular tests, such as RT-PCR tests, that detect the virus’s genetic material, and antigen tests that detect specific proteins from the virus. Based on end-user, the global COVID-19 diagnostics market can be classified into hospitals, physician's office & urgent care clinics, and diagnostic laboratories
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php? flag=CR&rep_id=80305 North America to Lead the Global COVID-19 Diagnostics Market
The global COVID-19 diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa